PharmaVoice / Karissa Waddick / November 9, 2022
29-year-old biotech founder Joe Landolina is hoping to capitalize on major possibilities in the human health market through his startup Cresilon and just inked a research partnership with Walter Reed.
Growing up on his grandparents’ vineyard, Joe Landolina had a lot of opportunities to get into trouble — but not the type you might think.
From a young age, Landolina would spend hours in the winery’s lab — a “glorified kitchen counter” with equipment he said was “borrowed” from his grandfather’s time in Big Pharma — conducting chemical experiments with the grapes and other plants he grew “with and without” his parents’ knowledge.
Read the full article here: